Key Client Fiduciary Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Key Client Fiduciary Advisors's MRK Position: Q2 2026 in Review
Key Client Fiduciary Advisors increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $21.8K and bringing the position to 7,589 shares worth $975K. The position accounts for 0.28% of the portfolio, ranked #75.
Key Client Fiduciary Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.15M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Key Client Fiduciary Advisors held 7,589 shares of Merck worth $975K as of Q2 2026.
- Key Client Fiduciary Advisors bought 186 Merck shares in Q2 2026, an estimated $21.8K.
- Merck made up 0.28% of Key Client Fiduciary Advisors's portfolio in Q2 2026, its #75 holding.
- Key Client Fiduciary Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
- Key Client Fiduciary Advisors's Merck position peaked at $1.15M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Key Client Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.